AN OPEN-LABEL STUDY OF NALTREXONE AND BUPROPION COMBINATION THERAPY FOR SMOKING CESSATION IN OVERWEIGHT AND OBESE SUBJECTS

Kaydedildi:

WILCOX, C.S., ET AL., AN OPEN-LABEL STUDY OF NALTREXONE AND BUPROPION COMBINATION THERAPY FOR SMOKING CESSATION IN OVERWEIGHT AND OBESE SUBJECTS. Addictive Behaviors, Vol. 35, no. 3 (2010), p. 229-234.

Ref. 165734

Yer: SIIS R.992 Archivo

Solicitar documento

Palabras clave:
Drogodependencias, Efectos, Evaluación de servicios, Fármacos, Naltrexona, Tabaquismo, Tratamiento médico

Internet

Path
Enlace web pago

AN OPEN-LABEL STUDY OF NALTREXONE AND BUPROPION COMBINATION THERAPY FOR SMOKING CESSATION IN OVERWEIGHT AND OBESE SUBJECTS

Internet

Benzer Materyaller